Wendel D, Cole CR, Cohran VC (2021) Approach to intestinal failure in children. Curr Gastroenterol Rep 23:8
Norsa L, Nicastro E, Di Giorgio A et al (2018) Prevention and treatment of intestinal failure-associated liver disease in children. Nutrients. https://doi.org/10.3390/nu10060664
Article PubMed PubMed Central Google Scholar
Modi BP, Galloway DP, Gura K et al (2022) ASPEN definitions in pediatric intestinal failure. JPEN J Parenter Enteral Nutr 46:42–59
Kelly DA (2006) Intestinal failure-associated liver disease: what do we know today? Gastroenterology 130:S70–S77
Article CAS PubMed Google Scholar
Intralipid [package insert]. Uppsala, Sweden: Fresenius Kabi; 2015. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020248s020lbl.pdf. Accessed 14 Apr 2023
Anez-Bustillos L, Dao DT, Baker MA et al (2016) Intravenous fat emulsion formulations for the adult and pediatric patient: understanding the differences. Nutr Clin Pract 31:596–609
Article CAS PubMed PubMed Central Google Scholar
Cober MP, Killu G, Brattain A et al (2012) Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr 160:421–427
Article CAS PubMed Google Scholar
SMOFlipid [package insert]. Uppsala, Sweden: Fresenius Kabi; 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/207648s005lbl.pdf. Accessed 14 Apr 2023
Raghu VK, Sevilla WMA, King DE et al (2022) Current practices in lipid emulsion utilization in the prevention and treatment of intestinal failure-associated liver disease: a survey of pediatric intestinal rehabilitation and transplant centers. JPEN J Parenter Enteral Nutr 46:1585–1592
Article CAS PubMed Google Scholar
Fenton TR, Kim JH (2013) A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 13:59
Article PubMed PubMed Central Google Scholar
(2022) Growth Charts—WHO Child growth standards. https://www.cdc.gov/growthcharts/who_charts.htm#The%20WHO%20Growth%20Charts. Accessed 14 Apr 2023
Goulet O, Antébi H, Wolf C et al (2010) A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 34:485–495
Article CAS PubMed Google Scholar
Muhammed R, Bremner R, Protheroe S et al (2012) Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr 54:797–802
Article CAS PubMed Google Scholar
Diamond IR, Grant RC, Pencharz PB et al (2017) Preventing the progression of intestinal failure-associated liver disease in infants using a composite lipid emulsion: a pilot randomized controlled trial of SMOFlipid. JPEN J Parenter Enteral Nutr 41:866–877
Article CAS PubMed Google Scholar
Belza C, Wales JC, Courtney-Martin G et al (2020) An Observational study of smoflipid vs intralipid on the evolution of intestinal failure-associated liver disease in infants with intestinal failure. JPEN J Parenter Enteral Nutr 44:688–696
Article CAS PubMed Google Scholar
Navaratnarajah N, Girard G, Sant’Anna G, et al (2022) The impact of a lipid injectable emulsion (SMOF) on conjugated bilirubin levels in children receiving prolonged parenteral nutrition: a large single center experience. Clin Nutr ESPEN 49:289–294
Casson C, Nguyen V, Nayak P et al (2020) A Comparison of smoflipid® and intralipid® in the early management of infants with intestinal failure. J Pediatr Surg 55:153–157
Kulpins D, Pickney C, Garb M et al (2023) Neonatal intensive care unit mixed lipid emulsion use associated with reduced cholestasis at discharge in surgical patients. J Surg Res 287:1–7
Hudson AS, Tyminski N, Turner JM, Silverman JA (2023) Intestinal failure-associated liver disease and growth pre- and post-transition to a composite lipid emulsion. J Pediatr Gastroenterol Nutr 76:830–836
Article CAS PubMed Google Scholar
Wassef J, Lipkin E, Hardigan P, Duro D (2022) Trends in liver profile and nutrition outcomes in children undergoing intestinal rehabilitation using a mixed lipid injectable emulsion. Nutr Clin Pract 37:1180–1189
Article CAS PubMed Google Scholar
Yu LJ, Anez-Bustillos L, Mitchell PD et al (2023) Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion. JPEN J Parenter Enteral Nutr 47:30–40
Article CAS PubMed Google Scholar
Lam CKL, Church PC, Haliburton B et al (2018) Long-term exposure of children to a mixed lipid emulsion is less hepatotoxic than soybean-based lipid emulsion. J Pediatr Gastroenterol Nutr 66:501–504
Article CAS PubMed Google Scholar
Sanchez SE, Braun LP, Mercer LD et al (2013) The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants. J Pediatr Surg 48:573–578
Rollins MD, Ward RM, Jackson WD et al (2013) Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study. J Pediatr Surg 48:1348–1356
Nehra D, Fallon EM, Carlson SJ et al (2013) Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr 37:498–505
Article CAS PubMed Google Scholar
Levit OL, Calkins KL, Gibson LC et al (2016) Low-dose intravenous soybean oil emulsion for prevention of cholestasis in preterm neonates. JPEN J Parenter Enteral Nutr 40:374–382
Article CAS PubMed Google Scholar
Memon N, Hussein K, Hegyi T et al (2019) Essential fatty acid deficiency with SMOFlipid reduction in an infant with intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr 43:438–441
Article CAS PubMed Google Scholar
Carey AN, Rudie C, Mitchell PD et al (2019) Essential fatty acid status in surgical infants receiving parenteral nutrition with a composite lipid emulsion: a case series. JPEN J Parenter Enteral Nutr 43:305–310
留言 (0)